Veidlapa Nr. M-3 (8)
Study Course Description

Pharmaceutical Care of Oncology Patients in Inpatient and Outpatient Settings

Main Study Course Information

Course Code
LFK_049
Branch of Science
Basic medicine; Clinical Pharmacy
ECTS
3.00
Target Audience
Clinical Pharmacy
LQF
Level 7
Study Type And Form
Full-Time

Study Course Implementer

Course Supervisor
Structure Unit Manager
Structural Unit
Department of Applied Pharmacy
Contacts

Riga, Dzirciema street 16, zftk@rsu.lv, +371 67061547

About Study Course

Objective

To develop an understanding of the pathway of chemotherapy and other oncology drugs from prescription to administration to the oncology patient and the role of the clinical pharmacist in this process: 1. To learn in depth the topics necessary for the work of a clinical pharmacist, such as the safe and rational use of medicinal products in oncology, dosing, including for patients with organ dysfunction, side effects and interactions of medicines, monitoring. 2. To improve students’ ability to identify and solve pharmacotherapy problems in oncology.

Preliminary Knowledge

Knowledge of clinical pharmacology, biochemistry, dosage form technology.

Learning Outcomes

Knowledge

1.Pharmacology of medicines used in oncology, interactions the most common drug combinations used in oncology, specifics of prescribing and administration, safe handling of cytostatic medicines in inpatient and outpatient settings, specifics of paediatric oncology.

Skills

1.The student will be able to solve practical tasks, clinically analyse therapy and clinical case, gain experience in the analysis of standard therapies in adult and paediatric oncology, skills in safe circulation of medicinal products.

Competences

1.Knowledge of medicines used in adult and paediatric oncology, interactions and dosing, analysis of therapy.

Assessment

Individual work

Title
% from total grade
Grade
1.

Individual work

-
-
Attending lectures in person, independently studying the literature, solving situational problems, discussing them together in a seminar.

Examination

Title
% from total grade
Grade
1.

Examination

-
-
Attendance of lectures and classes, active participation; homework submitted on time and done in high quality. The exam assesses the ability to independently solve situational tasks and the existing theoretical knowledge of the material presented.

Study Course Theme Plan

FULL-TIME
Part 1
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Groups of medicines used in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Groups of medicines used in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Therapy for the most common diseases in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Therapy for the most common diseases in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Paediatric oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjusting the dosage of medicines in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjusting the dosage of medicines in oncology
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjusting the dosage of medicines in oncology
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjusting the dosage of medicines in oncology
  1. Lecture

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjuvant therapies in oncology, problem solving
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjuvant therapies in oncology, problem solving
  1. Class/Seminar

Modality
Location
Contact hours
On site
Auditorium
2

Topics

Adjuvant therapies in oncology, problem solving
Total ECTS (Creditpoints):
3.00
Contact hours:
24 Academic Hours
Final Examination:
Exam

Bibliography

Required Reading

1.

Lekciju un praktisko nodarbību materiāli

Additional Reading

1.

QuapoS 5. Quality Standard for the Oncology Pharmacy Service. Published by German Society of Oncology

2.

Eudralex, Volume 4. Medicinal products for human and veterinary use, GMP // Annex 1. Manufacture of sterile products

3.

Roger Walker, Kate Whittlesea. Clinical Pharmacy and Therapeutics, 5th ed., 2012

Other Information Sources

1.

British National Formulary. 2019

2.

British National Formulary for children